Press

This forum will introduce the current status and case studies of DCT-related services, which are being increasingly adopted in Japan, as well as various solutions related to clinical trial digital transformation.
Buzzreach will be taking part in Part 2: “Introduction of Solutions from Various Companies” from 16:10-16:30 (First Hall) , and Part 3: “Panel Discussion – Challenges and Realities of DCT Implementation – How Stakeholders in Clinical Trials Share Challenges and Find Solutions,” with CEO Ikawa and GM Fukunaga of the Site Relations Department, PF Promotion Division.

Event summary:

“eClinical Solutions Forum 2025” hosted by the Japan CRO Association
Date and time: Tuesday, November 11, 2025, 13:00-19:30
Participation fee: Free
Venue: Nihonbashi Life Science Hub
Address: 1-5-5 Muromachi, Nihonbashi, Chuo-ku, Tokyo (Muromachi Chibagin Mitsui Building Office Building, 8th floor)

Part 1: 13:00-14:10 “Plenary Session”
13:00-13:05
　Opening Remarks by Toru Fujieda, Chairman of the Japan CRO Association
13:05-13:45
　Keynote Speech: The “Ideal” and “Reality” of DCT: Chugai Pharmaceutical’s Initiatives and the Barriers to Overcome
　by Ryutaro Sato, Chugai Clinical Research Center, Inc.
13:45-14:10
　Promotion of the Clinical Trial Ecosystem as a CRO Association
　Policy Committee Member, Japan CRO Association / Tomoko Komine, IQVIA Services Japan, LLC

Part 2: 14:20-16:55 “Introduction to Solutions from Each Company”
　16:10-16:30 Venue 1: Buzzreach, Inc.

“Buzzreach’s Clinical Trial Ecosystem: A Near-Future Vision of Clinical Trials as Medical Institution-Driven Digitalization Advances”
In recent years, the clinical trial environment has undergone major transformation, creating an urgent need to build a “clinical trial ecosystem” to realize patient-centric clinical trials. In Japan, in particular, improving case accumulation and consolidating clinical trial sites have become key issues. Decentralized clinical trials (DCT) offer a solution to these issues by reducing the burden on participants, expanding participation opportunities, improving case accumulation, and enabling collaboration with partner site regional medical networks. The time has come for this Japanese-style DCT clinical trial format to become the norm in the future. It is attracting attention. In this session, we will consider the direction of DCT suited to the Japanese model, which starts with clinical trial institutions and enables improved case accumulation and the consolidation of clinical trial institutions, based on both domestic and international examples of successful and unsuccessful DCT, and co-creates with partner sites. We will also paint a picture of the near future of the clinical trial industry as digital transformation advances, and discuss how to realize clinical trials that are a win-win for sponsors, medical institutions, and patients. Part

3: 17:05-17:50 “Panel Discussion” –
Challenges and Realities of Introducing DCT –
“How Stakeholders in Clinical Trials Share Issues and Find Solutions”

Part 4: 17:55-18:00 Closing Remarks　
　by Takenori Ogawa, Advisor, Japan CRO Association

For more information on the event, please visit:
https://www.jcroa.or.jp/seminar/seminar-5995